Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.

Cross BW, Johnson TV, Derosa AB, Ogan K, Pattaras JG, Nieh PT, Kucuk O, Harris WB, Master VA.

Int J Surg Oncol. 2012;2012:524981. doi: 10.1155/2012/524981. Epub 2012 Jul 29.

2.

The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.

Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED.

Cancer. 2006 Jan 15;106(2):304-12.

3.
4.

Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.

Johnson TV, Ali S, Abbasi A, Kucuk O, Harris WB, Ogan K, Pattaras J, Nieh PT, Marshall FF, Osunkoya AO, Master VA.

J Urol. 2011 Oct;186(4):1213-7. doi: 10.1016/j.juro.2011.06.014. Epub 2011 Aug 17.

PMID:
21849188
5.

Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young A, Ogan K, Pattaras J, Nieh P, Marshall FF, Master VA.

J Urol. 2010 Feb;183(2):480-5. doi: 10.1016/j.juro.2009.10.014. Epub 2009 Dec 14.

PMID:
20006861
6.

Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less.

Kates M, Badalato GM, Pitman M, McKiernan JM.

J Urol. 2011 Oct;186(4):1247-53. doi: 10.1016/j.juro.2011.05.054. Epub 2011 Aug 17.

PMID:
21849201
7.

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.

Eur Urol. 1999;36(1):21-30.

PMID:
10364651
8.

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS.

J Urol. 2005 Aug;174(2):466-72; discussion 472; quiz 801.

PMID:
16006866
9.

Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.

Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P.

J Clin Oncol. 2006 Jul 1;24(19):3101-6.

10.

Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.

Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS.

BJU Int. 2012 Oct;110(7):956-60. doi: 10.1111/j.1464-410X.2012.10937.x. Epub 2012 Feb 2.

11.

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.

Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.

J Urol. 2001 Jul;166(1):68-72.

PMID:
11435825
12.
13.

Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.

May M, Brookman-Amissah S, Kendel F, Knoll N, Roigas J, Hoschke B, Miller K, Gilfrich C, Pflanz S, Gralla O.

Int J Urol. 2009 Jul;16(7):616-21. doi: 10.1111/j.1442-2042.2009.02319.x. Epub 2009 May 13.

14.

Onodera's Prognostic Nutritional Index as an independent prognostic factor in Clear Cell Renal Cell Carcinoma.

Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master VA.

Urology. 2016 Jul 15. pii: S0090-4295(16)30398-3. doi: 10.1016/j.urology.2016.05.064. [Epub ahead of print]

PMID:
27431662
15.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
16.

Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.

Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.

BJU Int. 2012 May;109(10):1457-62. doi: 10.1111/j.1464-410X.2011.10597.x. Epub 2011 Sep 20.

17.

Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.

Harada K, Miyake H, Kusuda Y, Fujisawa M.

BJU Int. 2012 Dec;110(11 Pt C):E1131-7. doi: 10.1111/j.1464-410X.2012.11297.x. Epub 2012 Jun 19.

18.

External validation of the modified Glasgow prognostic score for renal cancer.

Tai CG, Johnson TV, Abbasi A, Herrell L, Harris WB, Kucuk O, Canter DJ, Ogan K, Pattaras JG, Nieh PT, Master VA.

Indian J Urol. 2014 Jan;30(1):33-7. doi: 10.4103/0970-1591.124203.

19.

[Value of the postoperative Störkel score. Predict disease-free survival of patients with surgically resected renal cell carcinoma].

May M, Brookman-Amissah S, Pflanz S, Knoll N, Roigas J, Gunia S, Hoschke B, Kendel F.

Urologe A. 2009 Mar;48(3):284-90. doi: 10.1007/s00120-008-1912-1. German.

PMID:
19104768
20.

Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.

Jeon HG, Gong IH, Hwang JH, Choi DK, Lee SR, Park DS.

BJU Int. 2012 May;109(10):1468-73. doi: 10.1111/j.1464-410X.2011.10531.x. Epub 2011 Aug 25.

Items per page

Supplemental Content

Write to the Help Desk